Literature DB >> 24876171

Depression and suicidality in COPD: understandable reaction or independent disorders?

Ulrich Hegerl1, Roland Mergl2.   

Abstract

Both depression and chronic obstructive pulmonary disease (COPD) are prevalent, severe and often comorbid disorders. There is a risk of undertreatment for depression in patients with COPD as depressive symptoms, including suicidal tendencies, can erroneously be conceptualised as an understandable reaction to COPD and not as signs of an independent depressive disorder. In this context, the comorbidity rates of COPD and depression, the risk of suicidal behaviour in patients with COPD, and the evidence base for pharmaco- and psychotherapy in these patients are reviewed. Because symptoms of depression and COPD overlap it remains unclear how far the prevalence of major depression in COPD exceeds that in the general population. The suicide risk appears to be increased in COPD. Methodological studies providing evidence for the antidepressant efficacy of antidepressants or psychotherapy in patients with COPD are lacking. Recommendations for clinicians on how to separate depression from an understandable reaction to COPD are provided. Given the profound effects of depression on quality of life, life expectancy, COPD prognosis and suicide risk it is important to carefully diagnose and treat depression in patients with COPD according to national guidelines. ©ERS 2014.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24876171     DOI: 10.1183/09031936.00193213

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  9 in total

Review 1.  Anxiety and Depression in Chronic Obstructive Pulmonary Disease: Perspectives on the Use of Hypnosis.

Authors:  Hernán Anlló; François Larue; Bertrand Herer
Journal:  Front Psychol       Date:  2022-05-19

2.  Gender and age differences in the association between work stress and incident depressive symptoms among Korean employees: a cohort study.

Authors:  Sun-Young Kim; Young-Chul Shin; Kang-Seob Oh; Dong-Won Shin; Weon-Jeong Lim; Sung Joon Cho; Sang-Won Jeon
Journal:  Int Arch Occup Environ Health       Date:  2019-12-03       Impact factor: 3.015

3.  Psychological therapies for the treatment of depression in chronic obstructive pulmonary disease.

Authors:  Justyna Pollok; Joep Em van Agteren; Adrian J Esterman; Kristin V Carson-Chahhoud
Journal:  Cochrane Database Syst Rev       Date:  2019-03-06

4.  Prevalence and correlates of suicide ideation in patients with COPD: a mixed methods study.

Authors:  Sara Fleehart; Vincent S Fan; Huong Q Nguyen; Jungeun Lee; Ruth Kohen; Jerald R Herting; Gustavo Matute-Bello; Sandra G Adams; Genevieve Pagalilauan; Soo Borson
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2014-12-04

5.  Hospitalisation for chronic obstructive pulmonary disease and risk of suicide: a population-based case-control study.

Authors:  Jennie Maria Christin Strid; Christian Fynbo Christiansen; Morten Olsen; Ping Qin
Journal:  BMJ Open       Date:  2014-11-24       Impact factor: 2.692

Review 6.  Overview of the prevalence, impact, and management of depression and anxiety in chronic obstructive pulmonary disease.

Authors:  Maria Panagioti; Charlotte Scott; Amy Blakemore; Peter A Coventry
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2014-11-13

Review 7.  Strategies to improve anxiety and depression in patients with COPD: a mental health perspective.

Authors:  Athanasios Tselebis; Argyro Pachi; Ioannis Ilias; Epaminondas Kosmas; Dionisios Bratis; Georgios Moussas; Nikolaos Tzanakis
Journal:  Neuropsychiatr Dis Treat       Date:  2016-02-09       Impact factor: 2.570

8.  Hypnosis for the management of COPD-related anxiety and dyspnoea in pulmonary rehabilitation: rationale and design for a cluster-randomised, active-control trial (HYPNOBPCO_2).

Authors:  Hernán Anlló; Bertrand Herer; Agathe Delignières; Adelina Ghergan; Yolaine Bocahu; Isabelle Segundo; Cécile Moulin; François Larue
Journal:  ERJ Open Res       Date:  2021-02-07

9.  Hypnosis for the Management of Anxiety and Dyspnea in COPD: A Randomized, Sham-Controlled Crossover Trial.

Authors:  Hernán Anlló; Bertrand Herer; Agathe Delignières; Yolaine Bocahu; Isabelle Segundo; Valérie Mach Alingrin; Marion Gilbert; François Larue
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-10-22
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.